Oseltamivir
CHEBI:CHEBI_7798
Definition
A cyclohexenecarboxylate ester that is the ethyl ester of oseltamivir acid. An antiviral prodrug (it is hydrolysed to the active free carboxylic acid in the liver), it is used to slow the spread of influenza.
Chemical Information
- Molecular Formula
- C16H28N2O4
- Molecular Mass
- 312.40450
- Charge
- 0
- SMILES
- CCOC(=O)C1=C[C@@H](OC(CC)CC)[C@H](NC(C)=O)[C@@H](N)C1
- InChI
- InChI=1S/C16H28N2O4/c1-5-12(6-2)22-14-9-11(16(20)21-7-3)8-13(17)15(14)18-10(4)19/h9,12-15H,5-8,17H2,1-4H3,(H,18,19)/t13-,14+,15+/m0/s1
- InChIKey
- VSZGPKBBMSAYNT-RRFJBIMHSA-N
Alternative Names
- (-)-oseltamivir
- 1-Cyclohexene-1-carboxylic acid, 4-(acetylamino)-5-amino-3-(1-ethylpropoxy)-, ethyl ester, (3R-(3alpha,4beta,5alpha))-
- Agucort
- Ethyl (3R,4R,5S)-4-acetamido-5-amino-3-(1-ethylpropoxy)-1-cyclohexene-1-carboxylate
- ethyl (3R,4R,5S)-4-acetamido-5-amino-3-(pentan-3-yloxy)cyclohex-1-ene-1-carboxylate
- GS-4104
- HSDB 7433
- oseltamivir
- Oseltamivir
- oseltamivirum
- Tamiflu
Drug Classification
-
acetamidesView Class →
CHEBI:22160
-
primary amino compoundView Class →
CHEBI:50994
-
amino acid esterView Class →
CHEBI:46668
-
cyclohexenecarboxylate esterView Class →
CHEBI:37529
-
t296081
-
t296291
-
t296617
-
t297055
Important Medical Information
⚕️ This information is sourced from ChEBI (Chemical Entities of Biological Interest) database and is intended for educational purposes only.
- Always consult with a healthcare professional before starting, stopping, or modifying any medication.
- Side effects may vary and this list may not be comprehensive.
- Drug interactions may occur with other medications.
Additional Identifiers
- DRON_00010000
- 260101
- oboInOwl#hasDbXref
- Wikipedia:Oseltamivir
- core#notation
- CHEBI:7798
Additional References
🔍 Click on any linked disease name to learn more about the conditions this medication is used to treat, or explore related drug classifications for more information about similar medications.
Additional Attributes
- labeler_name
- Cipla USA, Inc
- marketing_start_date
- 20180221
- application_number
- ANDA217451
- product_type
- BULK INGREDIENT
- marketing_category
- BULK INGREDIENT
- dosage_form
- FOR SUSPENSION
- product_ndc
- 69315-174
- route
- ORAL
- package_ndc
- 63552-146-00
- spl_id
- f7a7d52e-3c06-40ba-e053-6294a90af0ed
- package_marketing_start_date
- 21-FEB-22
- package_description
- 1 BLISTER PACK in 1 CARTON (70710-1010-2) / 10 CAPSULE in 1 BLISTER PACK
- rxcui
- 1115700
- manufacturer_name
- Cipla USA, Inc
- unii
- 4A3O49NGEZ
- spl_set_id
- 46dda802-32b8-4608-8eae-97e2cfc57472
- oboInOwl#hasOBONamespace
- chebi_ontology
- DRON_00010000
- 260101
- oboInOwl#hasDbXref
- Wikipedia:Oseltamivir
- oboInOwl#hasAlternativeId
- CHEBI:42582
- oboInOwl#id
- CHEBI:7798
- generic_name
- OSELTAMIVIR
- brand_name
- Oseltamivir Phosphate for Oral Suspension
- brand_name_base
- Oseltamivir Phosphate for Oral Suspension
- oboInOwl#inSubset
- http://purl.obolibrary.org/obo/chebi#3_STAR
- RO_0000087
- http://purl.obolibrary.org/obo/CHEBI_50266
- core#notation
- CHEBI:7798
- pharm_class
- Neuraminidase Inhibitor [EPC]
- 22-rdf-syntax-ns#type
- http://www.w3.org/2002/07/owl#Class
- active_ingredient_strength
- 75 mg/kg
- active_ingredient_name
- OSELTAMIVIR PHOSPHATE
- upc
- 0372205060784
- listing_expiration_date
- 20241231
- has_treatment
- http://purl.obolibrary.org/obo/DOID_4492
- rdf-schema#domain
- https://w3id.org/def/predibionto#has_side_effect34947
- owl#annotatedSource
- t297210
- owl#someValuesFrom
- t985656